Caviglia, G.P.; Nicolosi, A.; Abate, M.L.; Carucci, P.; Rosso, C.; Rolle, E.; Armandi, A.; Aneli, S.; Olivero, A.; Risso, A.;
et al. Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease. Curr. Oncol. 2022, 29, 5457-5465.
https://doi.org/10.3390/curroncol29080431
AMA Style
Caviglia GP, Nicolosi A, Abate ML, Carucci P, Rosso C, Rolle E, Armandi A, Aneli S, Olivero A, Risso A,
et al. Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease. Current Oncology. 2022; 29(8):5457-5465.
https://doi.org/10.3390/curroncol29080431
Chicago/Turabian Style
Caviglia, Gian Paolo, Aurora Nicolosi, Maria Lorena Abate, Patrizia Carucci, Chiara Rosso, Emanuela Rolle, Angelo Armandi, Serena Aneli, Antonella Olivero, Alessandra Risso,
and et al. 2022. "Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease" Current Oncology 29, no. 8: 5457-5465.
https://doi.org/10.3390/curroncol29080431
APA Style
Caviglia, G. P., Nicolosi, A., Abate, M. L., Carucci, P., Rosso, C., Rolle, E., Armandi, A., Aneli, S., Olivero, A., Risso, A., Ribaldone, D. G., Fermer, C., Saracco, G. M., Gaia, S., & Bugianesi, E.
(2022). Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease. Current Oncology, 29(8), 5457-5465.
https://doi.org/10.3390/curroncol29080431
